GB Sciences, Inc. (OTCMKTS:GBLX – Get Free Report) passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.01 and traded as low as $0.00. GB Sciences shares last traded at $0.00, with a volume of 34,148 shares traded.
GB Sciences Stock Performance
The business’s 50-day moving average price is $0.01 and its 200 day moving average price is $0.01.
About GB Sciences
GB Sciences, Inc, a phytomedical research and biopharmaceutical drug development company, engages in the research and development of plant-based medicines. The company offers cannabinoid-inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of medical conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular therapeutic programs.
Recommended Stories
- Five stocks we like better than GB Sciences
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Energy Vault Soars 100%: CEO Shares Why in MarketBeat Exclusive
- What Are Dividend Champions? How to Invest in the Champions
- Meta’s Q3 Earnings Beat—Is This Dip a Golden Entry Opportunity?
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Top Nuclear Stocks Thriving on Soaring Energy Demand
Receive News & Ratings for GB Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GB Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
